Eucomed's UDI guidance
This article was originally published in The Gray Sheet
Executive Summary
European trade association Eucomed's 1guidance on implementation of Unique Device Identification (UDI), issued July 22, "strongly advocates a standardized approach" based on global standards with regard to UDI. The trade association notes that its members are increasingly using two-dimensional bar codes to identify their products and that these should continue to be used in parallel with radio frequency identification (RFID) as problems with RFID are worked out. Eucomed is also in favor of a risk-based approach to tracking and tracing that focuses on the highest risk devices first and exempts low-risk device categories
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.